Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
BioOptics Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about AstraZeneca PLC
Recent news which mentions AstraZeneca PLC
< Previous
1
2
3
4
Next >
Healthy Returns: The first round of Medicare drug price negotiations is nearing an end
July 23, 2024
Tags
Johnson & Johnson
Merck & Co Inc
Novo Nordisk A/S
From
CNBC.com News
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
June 07, 2024
Tags
Johnson & Johnson
Eli Lilly and Co
Merck & Co Inc
From
CNBC.com News
Why CEO AstraZeneca believes the pharmaceutical company can almost double revenues by 2030
June 04, 2024
Tickers
CEO
Tags
Markets
Stock Picks
AstraZeneca PLC
From
CNBC.com News
Cramer's Lighting Round: 'You've got a winner' with Astra Zeneca
May 31, 2024
Tags
Stock Picks
Market Outlook
Markets
From
CNBC.com News
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a hotbed for M&A
May 23, 2024
Tags
Breaking News: Investing
Biotech and Pharmaceuticals
Health care industry
From
CNBC.com News
AstraZeneca targets $80 billion in total revenue by 2030 with release of 20 new medicines
May 21, 2024
Tags
Medicine
World News
Europe News
From
CNBC.com News
Amgen, newer rivals could threaten Novo Nordisk and Eli Lilly's weight loss drug dominance
May 07, 2024
Tags
Business
Health care industry
Zealand Pharma A/S
From
CNBC.com News
FTC challenges 'junk' patents held by 10 drugmakers, including for Novo Nordisk's Ozempic
April 30, 2024
Tags
Health care industry
GSK plc
Business
From
CNBC.com News
Healthy Returns: Weight loss, diabetes drug ad spending tops $1 billion
April 03, 2024
Tags
Biotech and Pharmaceuticals
Eli Lilly and Co
Novo Nordisk A/S
From
CNBC.com News
Healthy Returns: Drugmakers are capping inhaler prices at $35 in a win for some patients
March 26, 2024
Tags
Health & Science
GSK plc
Healthy Returns
From
CNBC.com News
Healthy Returns: What’s next in the legal fight over Medicare drug price negotiations
March 13, 2024
Tags
Health care industry
Healthy Returns
AstraZeneca PLC
From
CNBC.com News
Judge rejects AstraZeneca’s challenge to Medicare drug price negotiations
March 01, 2024
Tags
Pharmaceuticals
Health & Science
Bristol/Myers Squibb Co
From
CNBC.com News
The pet drugs vets are now prescribing look a lot more like human medications
February 28, 2024
Tickers
CATS
DOGS
PETS
Tags
Animal health
Health insurance
Pfizer Inc
From
CNBC.com News
The 11 GRANOLAS stocks power Europe to record highs, drawing Magnificent Seven comparisons
February 27, 2024
Tags
Health & Science
AstraZeneca PLC
Roche Holding AG
From
CNBC.com News
Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that
February 10, 2024
Tags
Novo Nordisk A/S
Eli Lilly and Co
US: News
From
CNBC.com News
AI might be reading your Slack messages: 'A lot of this becomes thought crime'
February 09, 2024
Tags
Walmart Inc
Meta Platforms Inc
Breaking News: Technology
From
CNBC.com News
The weight loss drug market may soon get more crowded – here are the companies trying to enter the booming space
January 17, 2024
Tags
Structure Therapeutics Inc
Amgen Inc
Roche Holding AG
From
CNBC.com News
Biotech and pharma companies are betting on a promising class of cancer drugs to drive growth
January 14, 2024
Tags
Health & Science
Pharmaceuticals
AstraZeneca PLC
From
CNBC.com News
Cramer names biopharma companies to watch as industry mergers start to pile up
January 05, 2024
Tags
RayzeBio Inc
Investment strategy
Business
From
CNBC.com News
Biden administration's Medicare drug price negotiations will face major tests in 2024
December 28, 2023
Tags
Business News
Biotech and Pharmaceuticals
Biotechnology
From
CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
December 17, 2023
Tags
Pfizer Inc
US: News
Eli Lilly and Co
From
CNBC.com News
CDC expedites release of more doses of infant RSV drug from Sanofi, AstraZeneca amid shortage
November 17, 2023
Tags
Breaking news
Companies
Business
From
CNBC.com News
CNBC Daily Open: Bond yields resurge on Powell’s speech
November 09, 2023
Tags
Interest Rates
HSBC Holdings PLC
Daily Open
From
CNBC.com News
Ex-UK PM Liz Truss renews calls for Reagan-style tax cuts one year after mini-budget blowup
October 03, 2023
Tags
Europe Politics
Breaking News: Economy
Europe: Top News And Analysis
From
CNBC.com News
Drugmakers opt in to Medicare drug price negotiations – here's what happens next
October 02, 2023
Tags
US: News
Johnson & Johnson
Merck & Co Inc
From
CNBC.com News
Federal judge declines to block Medicare price negotiations
September 29, 2023
Tags
Abbvie Inc
AstraZeneca PLC
Bristol/Myers Squibb Co
From
CNBC.com News
AstraZeneca, Boehringer Ingelheim to participate in Medicare drug price negotiations
September 27, 2023
Tags
Biotechnology
Biotech and Pharmaceuticals
Business News
From
CNBC.com News
Stocks making the biggest moves in premarket trading: AstraZeneca, Paramount, Nike and more
September 25, 2023
Tags
Sealed Air Corp
Stock markets
Opendoor Technologies Inc
From
CNBC.com News
CDC advisors recommend Pfizer maternal RSV vaccine to protect infants
September 22, 2023
Tags
Health care industry
Business
Breaking news
From
CNBC.com News
Stocks making the biggest moves premarket: AstraZeneca, Wayfair, Alibaba and more
September 22, 2023
Tags
Economy
Breaking News: Markets
Business
From
CNBC.com News
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.